The main goals of Ulcerative Colitis (UC) treatment are to both induce and maintain the
clinical and endoscopic remission of disease, reduce the incidence of complications such as …

The goals for treatment of inflammatory bowel diseases (IBDs) are changing from
elimination of symptoms toward complete disease control—a process that demands both …

There are several scoring systems presently available to classify disease severity in
ulcerative colitis [UC] within the multiple domains of disease activity, which aid objective …

Currently, the main targets of drug therapy for ulcerative colitis [UC] are endoscopic and
clinical remission. However, there is active discussion about the additional advantages of …

Endoscopy plays an essential role in the diagnosis, management, prognosis, and
surveillance of inflammatory bowel disease (IBD), but surprisingly there are few available …

Background Endoscopic mucosal healing is an established treatment target for UC, yet the
value of achieving histological remission remains unclear. Aims To evaluate histological …

Background and aims: Advances in the medical management of inflammatory bowel
disease (IBD) have altered treatment targets. Endoscopic mucosal healing is associated …

Background & Aims Mucosal healing, determined by histologic analysis, is a potential
therapeutic target for patients with ulcerative colitis (UC). However, the histologic features of …

Ulcerative colitis (UC) is a disease of the mucosal layer, and activity of the disease is
assumed to be related to mucosal appearance. Mucosal healing has emerged as a major …

OBJECTIVES: Objective evidence of inflammation has been associated with the risk of
relapse in patients with ulcerative colitis (UC) who are in clinical remission. We compared …